介素-17在与炎症相关的癌症中的作用
Xingru Zhang1,2, Bangjie Li1, Tian Lan1,2
1The Eighth Clinical Medical College of Guangzhou University of Chinese Medicine, Foshan Hospital of Traditional Chinese Medicine, Foshan, Guangdong, China.
Frontiers in immunology
|February 5, 2025
概括
互乐金-17 (IL-17) 是一种关键的细胞因子,可以将炎症与癌症联系起来. 它在促进或抑制瘤生长方面的双重作用取决于背景,影响癌症治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 微生物学 微生物学
背景情况:
- 炎症越来越被认为是癌症发展和进展的驱动因素.
- 介素-17 (IL-17) 细胞因子家族是关键的调解者,将炎症与瘤发生联系起来.
- IL-17在癌症中的作用是复杂的,表现出前瘤和抗瘤效应.
研究的目的:
- 审查IL-17及其癌症受体的基本生物学.
- 讨论最近关于IL-17在炎症相关癌症中的类效应和机制的进展.
- 探索IL-17通过微生物群相互作用对癌症进展的影响及其治疗含义.
主要方法:
- 关于IL-17在癌症中的现有研究的文献评论.
- 在各种癌症中分析IL-17信号通路和受体表达.
- 研究微生物群,IL-17和瘤发育之间的相互作用.
主要成果:
- 在早期瘤发生过程中,IL-17信号可以直接促进瘤细胞的增殖.
- 在某些实验癌症模型中,IL-17已经证明了抗瘤免疫力.
- 微生物组动力学显著影响IL-17分泌和随后的瘤发育.
结论:
- 癌症中IL-17的特定功能取决于情境,因其分类,时空动力学和瘤阶段而有所不同.
- 了解IL-17的多方面的作用对于开发有效的癌症疗法至关重要.
- 准IL-17通路,可能与微生物群调节结合,对癌症治疗具有前途.
相关概念视频
T Cell Types and Functions
939
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
939
Tumor Immunotherapy
464
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
464
The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Inflammatory Response
1.8K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.8K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
114
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
114


